纳洛酮治疗脑梗死的疗效观察

目的　观察纳洛酮治疗脑梗死的疗效。方法　将 2 6 0例脑梗死患者随机分组 ,治疗组 12 8例 ,予纳洛酮治疗 ;对照组 132例 ,予一般治疗 ,观察神经功能缺损变化及血液流变学变化。结果　治疗组较对照组神经功能改善和血液流变学改变有显著性差异。结论　纳洛酮具有抗凝作用 ,对脑梗死患者神经功能恢复有较好疗效。     

Computational flow study of the continuous flow ventricular assist device, prototype number 3 blood pump

A computational fluid dynamics study of blood flow in the continuous flow ventricular assist device, Prototype No. 3 (CFVAD3), which consists of a 4 blade shrouded impeller fully supported in magnetic bearings, was performed. This study focused on the regions within the pump where return flow occurs to the pump inlet, and where potentially damaging shear stresses and flow stagnation might occur: the impeller blade passages and the narrow gap clearance regions between the impeller-rotor and pump housing. Two separate geometry models define the spacing between the pump housing and the impeller's hub and shroud, and a third geometry model defines the pump's impeller and curved blades. The flow fields in these regions were calculated for various operating conditions of the pump. Pump performance curves were calculated, which compare well with experimentally obtained data. For all pump operating conditions, the flow rates within the gap regions were predicted to be toward the inlet of the pump, thus recirculating a portion of the impeller flow. Two smaller gap clearance regions were numerically examined to reduce the recirculation and to improve pump efficiency. The computational and geometry models will be used in future studies of a smaller pump to determine increased pump efficiency and the risk of hemolysis due to shear stress, and to insure the washing of blood through the clearance regions to prevent thrombosis.     

Effects of new polymer-coated extracorporeal circuits on biocompatibility during cardiopulmonary bypass

An inflammatory response due to bioincompatibility of extracorporeal circuits is a major clinical issue during cardiopulmonary bypass (CPB). By using a swine model, we determined whether new polymer-coated circuits, the blood-contacting surfaces of which are coated with poly(2-methoxyethylacrylate) (PMEA), would reduce the inflammatory response during CPB. Plasma bradykinin levels and the percentages of CD35-positive monocytes in PMEA-coated circuits were significantly lower than those in uncoated circuits during CPB. The amount of proteins adsorbed on the PMEA-coated circuits was significantly lower than that on the uncoated circuits (0.30 microg/cm2 versus 3.42 microg/ cm2). Almost no IgG, IgM, or C3c/d was detected in proteins adsorbed on the PMEA-coated circuits although these proteins were clearly detected in proteins adsorbed on the uncoated circuits. We concluded that PMEA coating could reduce complement activation during CPB by suppressing the adsorption of IgG and IgM, which activate C3 via the classical pathway, on the surface of the circuits.     

战术药材储备的系统动力学研究

探讨战术药材储备系统模型的动力生质和行为方法：应用系统动力学方法和构建战术药材储备模型,借助于计算机编程,模拟有关参数变化时的系统行为。结果：初始储备量的大小对系统的平均库存量和平均缺货量无明显影响;目标储备量,到货速率和发化速度对平均存量和平均缺货量有显著影响。结论在有效控制到化速率的情况下,降低战术药材储备量对系统的保障效能无不利影响。     

EGF刺激下PIP2水解的数学模型

为了研究表皮生长因子刺激下细胞膜上磷脂酰肌醇二磷酸水解的动力学特性,我们根据质量作用定律和准稳态近似原则建立数学模型,模拟磷脂酰肌醇二磷酸的代谢;建立了磷脂酰肌醇二磷酸和表皮生长因子受体间浓度关系的微分方程,讨论了各个参数对磷脂酰肌醇二磷酸浓度变化趋势的影响。这个数学模型描述了磷脂酰肌醇二磷酸代谢的生物学特性以及关键信号分子间的浓度依赖关系。     

原发性开角型青光眼眼部血流动力学以及高血压对其的影响

目的　探讨原发性开角型青光眼眼部血流动力学以及高血压对其的影响。方法　研究对象为我院确诊的原发性开角型青光眼患者 4 9例 4 9眼 ,其中 19例有全身高血压病史。根据是否合并高血压分为 2组 ,应用彩色多普勒成像技术检测眼动脉 (OA)、视网膜中央动脉 (CRA)和后短睫状动脉 (SPCA)的血流动力学指标 ,取年龄相匹配的正常人 18例作为对照组。结果　青光眼患者的CRA及SPCA的收缩期峰值流速 (PSV) ,分别为 (7.6 4cm·s-1± 2 .6 0cm·s-1,9 2 1cm·s-1± 1.16cm·s-1)、舒张期血流速度 (EDV )(2 .0 4cm·s-1± 0 .95cm·s-1,2 .98cm·s-1± 0 .88cm·s-1)及平均流速 (MV) (3.87cm·s-1± 1 34cm·s-1,4 92cm·s-1±1 12cm·s-1)均低于正常对照组 ,阻力指数 (RI) (均为 0 70±0 0 6 )明显高于正常对照组。合并高血压的青光眼患者CRA及SPCA的PSV(9 4 5cm·s-1± 2 38cm·s-1,10 2 3cm·s-1±1 2 5cm·s-1)、EDV(3 0 8cm·s-1± 1 12cm·s-1,3 5 2cm·s-1± 1 10cm·s-1)和MV (4 92cm·s-1± 1 5 2cm·s-1,5 5 4cm·s-1± 1 2 6cm·s-1)明显高于非高血压的青光眼患者。结论　青光眼患者的球后血管的血流速度明显下降 ;无高血压的青光眼患者的血流速度低于合并全身高血压的青光眼患者。     

丁咯地尔对颈内动脉系统TIA患者的血流动力学及血液流变学的影响

目的观察丁咯地尔（意速）注射液治疗颈内动脉系统TIA患者的血流动力学及血液流变学的变化。方法选择颈内动脉系统TIA患者56例，随机分为两组，每组28例，治疗组用意速200mg加入生理盐水250ml静滴，对照组用复方丹参注射液30ml加入生理盐水250ml静滴，每天1次，疗程均为15天，治疗前后检测血流动力学及血液流变学指标变化。结果治疗组治疗前后血流动力学指标明显改善（P〈0．01），两组间比较差异亦有显著性（P〈0．05）。治疗组治疗前后血液流变学指标比较，差异有显著性（t=2．01～2．26，P〈0．05），两组间治疗后比较，差异亦有显著性（t=3．56～4．36，P〈0．01）。结论意速可有效改善颈内动脉系统TIA患者血流动力学及血液流变学指标。     

大孔吸附树脂分离肿节风中总黄酮的研究

目的考察11种大孔吸附树脂对肿节风总黄酮的吸附分离性能。方法采用静态吸附分离法确定适合的大孔吸附树脂;采用动态吸附分离法确定分离条件。以总黄酮吸附量、总黄酮质量分数和回收率为考察指标,采用紫外分光光度法测定总黄酮。结果HPD 400大孔吸附树脂对肿节风总黄酮有良好的吸附分离性能,其分离肿节风总黄酮的工艺条件为:肿节风总黄酮上样质量浓度为10 m g/mL,肿节风总黄酮最大吸附量为9.5 m g/mL,吸附体积流量为2.5 mL/m in,洗脱剂为70%乙醇,洗脱剂用量为3倍柱体积,树脂可重复使用3次。结论采用HPD 400大孔吸附树脂吸附分离肿节风总黄酮简便有效,总黄酮回收率为85%左右。     

血管抑素3A工程蛋白的柱复性与离子交换纯化

由大肠杆菌以包涵体形式表达的一种抗内皮细胞生长工程蛋白(A nti-ang iogen ic agent,简称3A)经变性,Sephacry l S-100 HR柱复性,SP Sepharose FF离子交换吸附纯化,SephadexG-25脱盐,获得复性率为53.47%,HPLC纯度为92.52%的3A活性蛋白。以猪髋动脉内皮细胞为受检细胞,表明纯化蛋白具有抑制内皮细胞生长的特性。     

肝苏缓释胶囊精制工艺中大孔吸附树脂型号的筛选

目的筛选适合分离纯化赶黄草提取物的最佳大孔吸附树脂型号。方法以槲皮素吸附量、解吸率、吸附速率及解吸速率为指标,对D140、D141、D3520、AB-8、D101、DM-130、NKA-9、S-8等8种大孔吸附树脂的性能进行比较。结果8种大孔吸附树脂对槲皮素的静态吸附量顺序为:D140>D141>D3520>AB-8>D101>DM-130>NKA-9>S-8,解吸率顺序为:D140>D141>S-8>AB-8>NKA-9>D3520>DM-130>D101。其中D140、D141对槲皮素的吸附量分别为9.728、.76m.g-1,解吸率分别为88.5%、84.3%;吸附速率和解吸速率比较结果表明,D140型树脂在加入药液后约5h吸附达到平衡,在加入解吸剂后1.5h解吸完全,其吸附、解吸速率最快。结论在8种树脂中,D140的吸附与解吸效果最佳。